Why Did Bill Ackman Buy Uber Stock?
In February, Pershing Square manager Bill Ackman revealed that his…
Buy
55
DRUG Quote, Financials, Valuation and Earnings
Last price:
$33.12
Seasonality move
:
-4.26%
Day range:
$33.23 - $34.73
52-week range:
$0.93 - $79.02
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.84x
Volume:
23.8K
Avg. volume:
32.3K
1-year change:
2966.06%
Market cap:
$235.4M
Revenue:
--
EPS (TTM):
-$0.18
Earnings Data
Next earnings date for DRUG
May 15
2025
Most recent earnings per share
$0.01
Beat by $0.35
(Feb 13/2025)
Consensus Estimate
-$0.35
(Feb 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DRUG Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | -- | -- | -- | -$0.47 | -- |
| 05/15/2025 | Q1 | -- | -- | -- | -$0.32 | -- |
| 02/13/2025 | Q4 | -- | -- | $0.01 | -$0.35 | $0.35 |
| 09/30/2024 | Q3 | -- | -- | -$0.12 | -$0.43 | $0.30 |
| 06/30/2024 | Q2 | -- | -- | $0.04 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.32 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.30 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.29 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.40 | -- | -- |
| 02/14/2023 | Q4 | -- | -- | -$0.48 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.77 | -- | -- |
| 08/30/2022 | Q2 | -- | -- | -$0.88 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.50 | -- | -- |
| 02/14/2022 | Q4 | -- | -- | -$1.63 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.97 | -- | -- |
| 08/30/2021 | Q2 | -- | -- | -$1.26 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.91 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.41 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.02 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.02 | -- | -- |
Bright Minds Biosciences Earnings Questions
-
How Much did Bright Minds Biosciences Generate in Revenue Last Quarter?
Bright Minds Biosciences reported -- worth of top line sales in its most recent quarter.
-
Did Bright Minds Biosciences Beat Earnings Last Quarter?
Bright Minds Biosciences announced earnings per share of $0.01 which represents a beat of analyst forecast a -$0.35 per share.
-
Is Bright Minds Biosciences Profitable?
Bright Minds Biosciences reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Bright Minds Biosciences EPS Next Year?
Bright Minds Biosciences's earnings are forecast to decrease from -$0.48 per share to -$0.78 per share next year representing a decrease of -183.9%.
-
When is Bright Minds Biosciences's Earnings Date?
Bright Minds Biosciences's next earnings date is May 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Should You Buy Alibaba Stock Despite the Risks?
Markets rebounded slightly after U.S. President Donald Trump announced a…
Why Is Intel Struggling Against AMD?
Due to its disappointing reports, so-so management, and lack of…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 36x
Alerts
Sell
48
FI alert for Apr 25
Fiserv [FI] is down 18.57% over the past day.
Buy
66
FARO alert for Apr 25
Faro Technologies [FARO] is up 17.99% over the past day.
Buy
55
PI alert for Apr 25
Impinj [PI] is up 16.61% over the past day.
